Bugworks Research Inc. to Present Poster at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2023, in Geneva, Switzerland

Bugworks Research is at the forefront of developing novel small molecule drugs to combat hard-to-treat cancers and drug-resistant bacterial infections.  The company is building a deep pipeline of differentiated oncology programs that target critical pathways involved in cancer progression and treatment evasion.  Bugworks Research is at the forefront of developing novel small molecule drugs to combat hard-to-treat cancers and drug-resistant bacterial infections.  The company is building a deep...

Bugworks Research is at the forefront of developing novel small molecule drugs to combat hard-to-treat cancers and drug-resistant bacterial infections.  The company is building a deep pipeline of differentiated oncology programs that target critical pathways involved in cancer progression and treatment evasion. 

The ESMO Immuno-Oncology Congress is an annual event offering a forum to present the latest scientific and clinical developments in immunotherapy to diverse stakeholders with an interest to deliver innovative treatments for cancer.  Attendees are invited to visit the Bugworks poster on December 7^th, 2023, between 12.00-1.00 CET.  

About Bugworks

Bugworks Research Inc. (Bugworks) is a clinical stage biopharmaceutical company, that is developing novel multi-target therapeutic assets in the anti-infective and oncology areas by integrating the latest innovations in computational biology, pharmacology, structural-biology, and medicinal chemistry.

For further information, please visit www.bugworksresearch.com

Logo: https://mma.prnewswire.com/media/2293179/Bugworks_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/bugworks-research-inc-to-present-poster-at-the-european-society-for-medical-oncology-esmo-immuno-oncology-congress-2023-in-geneva-switzerland-302007601.html